References
Anzai M, Yasu T, Gando Y, Shirota M, Kobayashi M (2022) Increased blood levels of venetoclax due to intake of crushed venetoclax tablets. Ann Hematol 101(9):2097–2098. https://doi.org/10.1007/s00277-022-04871-2
Yasu T, Gando Y, Nomura Y, Kosugi N, Kobayashi M (2022) Determination of venetoclax concentration in plasma using high-performance liquid chromatography. J Chromatogr Sci:bmac027. https://doi.org/10.1093/chromsci/bmac027
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244
Jermain SV, Brough C, Williams RO 3rd (2018) Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - an update. Int J Pharm 535(1–2):379–392. https://doi.org/10.1016/j.ijpharm.2017.10.051
Pas T, Verbert S, Appeltans B, Van den Mooter G (2020) The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics. Int J Pharm 573:118884. https://doi.org/10.1016/j.ijpharm.2019.118884
AbbVie Inc. (2021) VENCLEXTA® prescribing information. https://www.rxabbvie.com/pdf/venclexta.pdf. Accessed 2022 Aug 29
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yasu, T., Hikita, E., Gando, Y. et al. Impact of tablet crushing on the dissolution of venetoclax. Ann Hematol 102, 219–220 (2023). https://doi.org/10.1007/s00277-022-05014-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-05014-3